Filana Therapeutics, Inc.

Filana Therapeutics (FLNA): Simufilam on Clinical Hold as the TSC Epilepsy Program Defines the Stock

In-depth research on FLNA covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.